Rockville, Maryland – October 15, 2026 — The global remote patient monitoring for obesity market is projected to grow from USD 780 million in 2026 to USD 3.85 billion by 2036, registering a compound annual growth rate (CAGR) of 17.3% over the forecast period, according to Fact.MR. The market is benefiting from wider adoption of connected health devices, reimbursement support for remote patient monitoring, and increased emphasis on tracking weight changes between clinical visits.

Get detailed market forecasts, competitive benchmarking, and pricing trends: 

KEY MARKET TAKEAWAYS

• Market Valuation: USD 780 million in 2026, rising to USD 3.85 billion by 2036.
• Growth Rate: The market is forecast to expand at a CAGR of 17.3% from 2026 to 2036.
• Leading Monitoring Focus: Weight trajectory accounts for 47.4% of the market in 2026.
• Leading Device Type: Connected scales hold a 35.8% share.
• Fastest-Growing Country: The United States leads country-level growth at a 17.0% CAGR.
• Core Growth Driver: Wider adoption of connected devices and reimbursement pathways for remote monitoring are supporting demand.

INDUSTRY SHIFTS & MARKET DYNAMICS

Remote patient monitoring is becoming an important component of obesity management as healthcare providers seek to track patient progress outside traditional clinical settings. Connected scales and digital monitoring platforms allow care teams to collect weight measurements between appointments, supporting more consistent follow-up. Weight trajectory represents the leading monitoring focus, accounting for 47.4% of the market in 2026, while connected scales hold a 35.8% share by device type. The expansion of remote monitoring reimbursement is also helping healthcare organizations incorporate these technologies into ongoing care programs.

Despite these opportunities, measurement reliability and clinician workload remain important challenges. Inaccurate home readings can weaken the usefulness of collected data, while excessive alerts and unfiltered information may increase the burden on clinical teams. Reimbursement eligibility and program requirements can also influence the pace at which providers adopt remote monitoring. Suppliers that prioritize reliable measurements, actionable alerts, and practical integration into clinical workflows will be better positioned to address these requirements.

REGIONAL MARKET SUMMARY

Source: Fact.MR market study.

ANALYST INSIGHTS

“Remote patient monitoring for obesity is moving toward a model that combines reliable home-based measurements with reimbursement-supported clinical follow-up,” stated the Fact.MR healthcare research team. “Providers and technology suppliers that can convert patient data into actionable insights while keeping clinical workflows manageable are positioned to address emerging opportunities through 2036.”

Unlock 360° insights for strategic decision making and investment planning: 

FREQUENTLY ASKED QUESTIONS

Q: What is the projected size of the remote patient monitoring for obesity market by 2036?

A: The market is estimated at USD 780 million in 2026 and is projected to reach USD 3.85 billion by 2036, growing at a CAGR of 17.3%.

Q: Which monitoring focus holds the leading market share?

A: Weight trajectory is the leading monitoring focus, accounting for 47.4% of the market in 2026.

Q: Which device type leads the market?

A: Connected scales lead by device type, accounting for 35.8% of the market.

Q: Which country exhibits the highest growth rate?

A: The United States is projected to record the highest country-level growth among the reported leading markets, with a CAGR of 17.0% through 2036.

Q: What factors are driving market growth?

A: Wider use of connected devices, reimbursement support for remote patient monitoring, and demand for continuous weight tracking between clinical visits are key growth drivers.

Q: What challenges could restrict market expansion?

A: Measurement quality concerns, excessive data and alerts for clinicians, and reimbursement requirements may limit adoption.

Explore More Related Studies Published by Fact.MR Research

Familial Hypercholesterolemia Treatment Market

Smart Implants Market

About Fact.MR

Fact.MR is a market research and consulting firm providing syndicated research, customized research, investment research, and market intelligence across a broad range of industries. Its research coverage includes food and beverage, healthcare, pharmaceuticals, biotechnology, consumer products, chemicals and materials, technology, industrial goods, and packaging.

Fact.MR provides market intelligence designed to help organizations understand market dynamics, emerging opportunities, competitive developments, and changing industry requirements.

Media Contact

Fact.MR
Email: sales@factmr.com
Phone: +1 (628) 251-1583
Website: www.factmr.com